PRESS RELEASE published on 09/15/2025 at 09:05, 4 months 19 days ago BioNxt Advances Semaglutide Oral Dissolvable Film (ODF) Program with Successful Proof-of-Concept and Prototype Development BioNxt achieves successful proof-of-concept trials for Semaglutide oral dissolvable film program, advancing to next development phase in GLP-1 market for diabetes and obesity therapies Drug Delivery Semaglutide BioNxt GLP-1 Market Proof-of-concept
BRIEF published on 09/13/2025 at 01:05, 4 months 21 days ago BioNxt Settles Debt with Share and Cash Agreement Debt Settlement Canadian Securities Exchange Regulatory Approvals BioNxt Solutions Share Agreement
BRIEF published on 09/13/2025 at 01:05, 4 months 21 days ago BioNxt règle sa dette grâce à un accord en actions et en espèces Bourse Des Valeurs Canadiennes Approbations Réglementaires Règlement De La Dette Solutions BioNxt Accord De Partage
PRESS RELEASE published on 09/13/2025 at 01:00, 4 months 21 days ago BioNxt Announces Shares for Debt Settlement BioNxt Solutions Inc. announces a debt settlement agreement with a creditor, issuing common shares and making a cash payment. Company focuses on bioscience innovations and drug delivery technologies Innovation Debt Settlement BioScience Drug Delivery BioNxt
BRIEF published on 09/05/2025 at 09:10, 4 months 29 days ago BioNxt Solutions fait ses débuts sur le marché OTCQB Divulgation Financière Marché OTCQB Développement De Médicaments Investisseurs Américains Solutions BioNxt
BRIEF published on 09/05/2025 at 09:10, 4 months 29 days ago BioNxt Solutions Debuts on OTCQB Market Financial Disclosure Drug Development US Investors BioNxt Solutions OTCQB Market
PRESS RELEASE published on 09/05/2025 at 09:05, 4 months 29 days ago BioNxt Solutions Completes Up-Listing to The OTCQB Market BioNxt Solutions Inc. announces up-listing to OTCQB market, expanding access to US investors. Three drug development programs underway in Europe & North America. Company focuses on innovative drug delivery platforms Drug Development BioNxt Solutions Inc. US Investors OTCQB Market Innovative Drug Delivery
BRIEF published on 09/02/2025 at 09:10, 5 months 2 days ago BioNxt commence le développement à l'échelle du laboratoire d'un film oral à base de sémaglutide Solutions BioNxt Administration De Médicaments Semaglutide ODF Formulation À L'échelle Du Laboratoire Développement De Brevets
BRIEF published on 09/02/2025 at 09:10, 5 months 2 days ago BioNxt Begins Lab-Scale Development of Semaglutide Oral Film Drug Delivery BioNxt Solutions Semaglutide ODF Lab-scale Formulation Patent Development
PRESS RELEASE published on 09/02/2025 at 09:05, 5 months 2 days ago Semaglutide API Delivery Enables Start of Lab-Scale ODF Development at BioNxt BioNxt Solutions announces receipt of Semaglutide API for laboratory-scale testing of ODF delivery system. Collaboration with Gen Plus for European drug development hub BioNxt Solutions Semaglutide API ODF Delivery System Laboratory-scale Testing Gen Plus
Published on 02/05/2026 at 00:00, 27 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 2 hours 2 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 16:15, 8 hours 12 minutes ago Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 15:45, 8 hours 42 minutes ago Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Published on 02/04/2026 at 20:54, 3 hours 33 minutes ago Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 3 hours 51 minutes ago EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 4 hours 27 minutes ago Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 5 hours 32 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 5 hours 47 minutes ago Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:04, 6 hours 23 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 6 hours 23 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 6 hours 42 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 6 hours 42 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
